Medical treatment for urogenital tuberculosis (UGTB).

GMS infectious diseases Pub Date : 2018-08-09 eCollection Date: 2018-01-01 DOI:10.3205/id000039
Christian Wejse
{"title":"Medical treatment for urogenital tuberculosis (UGTB).","authors":"Christian Wejse","doi":"10.3205/id000039","DOIUrl":null,"url":null,"abstract":"<p><p>Urogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney abscess/malfunction, HIV co-infection). Treatment of multi-drug resistant tuberculosis (MDR-TB) requires use of long-term intravenous treatment with aminoglycosides and other drugs with considerable toxicity for 18-24 months. Complications such as urinary tract obstruction may occur and should be treated with corticosteroids or surgery.</p>","PeriodicalId":91688,"journal":{"name":"GMS infectious diseases","volume":"6 ","pages":"Doc04"},"PeriodicalIF":0.0000,"publicationDate":"2018-08-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.3205/id000039","citationCount":"14","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"GMS infectious diseases","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3205/id000039","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/1/1 0:00:00","PubModel":"eCollection","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 14

Abstract

Urogenital tuberculosis (UGTB) should in general be treated as pulmonary TB with a four-drug regimen of Isoniazid, Rifampicin, Ethambutol and Pyrazinamide for a total of 6 months, Ethambutol and Pyrazinamide only the first two months. Some patients may need longer treatment (cavitary disease, kidney abscess/malfunction, HIV co-infection). Treatment of multi-drug resistant tuberculosis (MDR-TB) requires use of long-term intravenous treatment with aminoglycosides and other drugs with considerable toxicity for 18-24 months. Complications such as urinary tract obstruction may occur and should be treated with corticosteroids or surgery.

Abstract Image

Abstract Image

Abstract Image

泌尿生殖系统结核病(UGTB)的医疗。
泌尿生殖系统结核(UGTB)一般应作为肺结核进行治疗,采用异烟肼、利福平、乙胺丁醇和吡嗪酰胺四种药物治疗方案,总共治疗6个月,乙胺丁醇和吡嗪酰胺仅在前两个月治疗。一些患者可能需要更长时间的治疗(空洞病、肾脓肿/功能障碍、HIV合并感染)。耐多药结核病(MDR-TB)的治疗需要使用氨基糖苷类药物和其他具有相当毒性的药物进行长期静脉治疗18-24个月。并发症如尿路梗阻可能发生,应使用皮质类固醇或手术治疗。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
审稿时长
17 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信